Picankibart

· Innovent Biopharmaceutical Technology (Hangzhou) Co., LTD.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Picankibart, covering 2026-03-20 to 2026-03-25. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Switching to Picankibart in Chinese Patients With Plaque Psoriasis With an Inadequate Response to Interleukin-17 Monoclonal Antibody Therapy [Phase 3]

See pricing